Endothelial progenitor cell transplantation decreases lymphangiogenesis and adverse myocardial remodeling in a mouse model of acute myocardial infarction

다국어 초록 (Multilingual Abstract)

Cardiac lymphatic system in the remodeling after acute myocardial infarction (AMI) has been overlooked. We wanted to investigate the role of bone marrow-derived endothelial progenitor cells (EPCs) and their contribution to lymphatic distribution in myocardial remodeling after AMI. Mouse (C57bl/6J) MI models were created by ligation of the left anterior descending coronary artery and were treated with phosphate buffered saline (PBS) or EPCs. Real-time RT-PCR with 2- to 4-week myocardial tissue samples revealed that lymphangiogenetic factors such as vascular endothelial growth factor (VEGF)-C (8.5 fold, P ＜ 0.05), VEGF-D (6.1 fold, P ＜ 0.05), Lyve-1 (15 fold, P ＜ 0.05), and Prox-1 (11 fold, P ＜ 0.05) were expressed at significantly higher levels in the PBS group than the EPC group. The PBS group also showed a significantly higher density of lymphatic vessels in the peri-infarction area. Echocardiography showed that from 2weeks after the treatment, left ventricle (LV) dimensions at both systole and diastole were significantly smaller in the EPC group than in the PBS group (P ＜ 0.01) and LV fractional shortening was higher in the EPC group accordingly (P ＜ 0.01).
Lymphangiogenic markers increased in a mouse MI model. EPC transplantation decreased lymphangiogenesis and adverse ventricular remodeling after AMI.
These novel findings suggest that new lymphatic vessels may be formed in severely damaged myocardium,and may be involved in adverse myocardial remodeling after AMI.

참고문헌 (Reference)

1 Miller AJ, "Ventricular endomyocardial changes after impairment of cardiac lymph flow in dogs" 25 : 182-190, 1963

2 Badorff C, "Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes" 107 : 1024-1032, 2003

3 Kawamoto A, "Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia" 103 : 634-637, 2001

4 Miller AJ, "The importance of the lymphatics of the mammalian heart: experimental observations and some speculations" 29 : 485-487, 1964

5 Lodge-Patch I, "The ageing of cardiac infarcts, and its influence on cardiac rupture" 13 : 37-42, 1951

6 Fumiyuki Hattori, "Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium" 생화학분자생물학회 42 (42): 155-165, 2010

7 Ishikawa Y, "Sequential changes in localization of repairrelated proteins (heat shock protein 70, ubiquitin and vascular endothelial growth factor) in the different stages of myocardial infarction" 37 : 546-554, 2000

8 Cho HJ, "Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart" Rockefeller University Press 204 (204): 3257-3269, 2007

9 Gonzales C, "Progenitor cell therapy for heart disease" 315 : 3077-3085, 2009

10 Anversa P, "Myocyte renewal and ventricular remodelling" 415 : 240-243, 2002

11 Sun Y, "Myocardial repair/remodelling following infarction: roles of local factors" 81 : 482-490, 2009

12 Mehlhorn U, "Myocardial fluid balance" 20 : 1220-1230, 2001

13 Ren G, "Morphological characteristics of the microvasculature in healing myocardial infarcts" 50 : 71-79, 2002

14 Ishikawa Y, "Lymphangiogenesis in myocardial remodelling after infarction" 51 : 345-353, 2007

15 변기현, "Is Stem Cell-Based Therapy Going on or Out for Cardiac Disease" 대한심장학회 39 (39): 87-92, 2009

16 Qin G, "Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization" 203 : 153-163, 2006

17 Ishikawa Y, "Expression of type V secretory phospholipase A in myocardial remodelling after infarction" 47 : 257-267, 2005

18 Hsieh PC, "Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury" 13 : 970-974, 2007

19 Ii M, "Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “"imported”" nitric oxide synthase activity" 111 : 1114-1120, 2005

20 Narmoneva DA, "Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration" 110 : 962-968, 2004

21 Rockson SG, "Diagnosis and management of lymphatic vascular disease" 52 : 799-806, 2008

22 Sun Y, "Cardiac remodeling by fibrous tissue after infarction in rats" 135 : 316-323, 2000

23 Asahara T, "Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization" 85 : 221-228, 1999

24 Young PP, "Biologic properties of endothelial progenitor cells and their potential for cell therapy" 49 : 421-429, 2007

25 Banai S, "Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs" 89 : 2183-2189, 1994

26 Feola M, "Alterations in cardiac lymph dynamics in acute myocardial ischemia in dogs" 23 : 299-305, 1977